Human testing of the first anti-nicotine vaccine has begun, according to
British drugs company Xenova. Medical director John Roberts says the drug could
help people quit because it prevents nicotine acting on the brain and so stops
addiction. Nicotine patches or gum simply substitute inhaled nicotine with a
more benign form. The vaccine will work best for smokers who risk relapsing
after quitting. The vaccine will stop a lapse of will power “sending you back to
the beginning of the craving cycle”, says Roberts.
To continue reading, today with our introductory offers
Advertisement
More from New ¾«¶«´«Ã½
Explore the latest news, articles and features
Popular articles
Trending New ¾«¶«´«Ã½ articles
1
Photos reveal unexpected details from the world's first atomic test
2
Does gravity create reality? A shocking path to a theory of everything
3
How a radical new view of life could reveal its origin – and aliens
4
NASA plans a base on the moon spanning hundreds of square kilometres
5
Earliest use of anaesthetics uncovered in Chinese doctor’s tomb
6
Attack on Iran’s oil released as much pollution as a volcano
7
Putting CO2 into rocks and getting hydrogen out is climate double win
8
First quantum grandfather clock could probe where gravity comes from
9
Can we harness quantum effects to create a new kind of healthcare?
10
What’s the secret to living well beyond the average life expectancy?
